On 20 August I was informed by my Internet Service Provider

New Post Public Reply Private Reply Replies (6) Message Board
patientgal
On 20 August I was informed by my Internet Service Provider that based on information provided and activities that I witnessed myself, a certain venue, that will remained unnamed at this juncture, "obviously has placed an IP tracker" on me. Are IP tracker's that big a deal? To some of us, heck yes. To others, no. What was disturbing about the information provided me is that based on what I had just experienced and in the amount of time it took for it to occur, I was most likely singled out. One of many I have no doubt. But to learn that I am among the elite pains in the arse was a bit disturbing to me.

On the same day I learned that my main system had been hacked. I literally spent more than 45 minutes on the phone with tech support to walk me through how to rid myself of these intruders.

Many of you will note that I became rather quiet around that time. Well, for me, that is.

The following day I conferred with a fellow investor who conveyed that he had experienced very similar to what I had just explained and that he has no doubt that there is a "hit list" so-to-speak and that we are among a number that are on this list.

I think few of you doubt whether Inventor and I made the trip to San Diego and met with David Koos and Dr. Ichim. Further, I think few of you doubt that there is a NDA in place and we are limited in what we can say about what we discussed or witnessed.

Given very recent activities whereby a few, who obviously feel very threatened by me, have gone to great lengths to discredit me as well it would seem, cover their behinds, I feel even more limited in what I can say. So, this is what I will say:

---As I have maintained from the very beginning, there is a HemaXellerate II in the pipeline.

---My findings suggest that Hema I & Hema II will be approved with Orphan Drug Status.

---My findings tell me that the preclinicals for the Min Science are going as planned and an IND application will be filed soon.

---My findings show that there is a massive short position that must be stopped, nay, will be stopped. The position is much greater than most know. Much greater. When and how this will be stopped? I do not know.

---My findings show that activities surrounding the intentional manipulation of this stock (and some others) is being closely monitored by authorities. I did not illegally list BMSN and other penny stocks on European exchanges. Nor did I in any way benefit from the illegal activities. Those that did however are being monitored BECAUSE of their activities and participation of what is known as "bashing" and "death spirals" and nothing that I have done.

---The following is a list of patents by Dr. Ichim. Some of these have been assigned to MEDS and other entities. The remaining are unassigned and are in the process of being executed. Based on what some of these are, one has to deduce that the final execution will go to Regen Biopharma or Bio-Matrix Scientific. If you look, you will see the obvious medical/scientific connections.

1 20130195899 THERAPEUTIC IMMUNE MODULATION BY STEM CELL SECRETED EXOSOMES
2 20130156847 METHODS OF INDUCING CELL DIFFERENTIATION WITH PLACENTAL EXTRACTS
3 20130156726 ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
4 20130015118 EXTRACORPOREAL REMOVAL OF MICROVESICULAR PARTICLES
5 20120269774 ALLOGENEIC STEM CELL TRANSPLANTS IN NON-CONDITIONED RECIPIENTS
6 20110104100 COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM
7 20110091434 AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSYLTRANSFERASE
8 20110070313 METHODS OF INDUCING CELL DIFFERENTIATION WITH PLACENTAL EXTRACTS
9 20100279291 GENE SILENCING OF THE BROTHER OF THE REGULATOR OF IMPRINTED SITES (BORIS)
10 20100008992 TREATMENT OF DISC DEGENERATIVE DISEASE AND COMPOSITIONS FOR SAME
11 20090311223 TREATMENT OF ERECTILE DYSFUNCTION BY STEM CELL THERAPY
12 20090304677 Extracorporeal Removal of Microvesicular Particles
13 20090291061 STEM CELL THERAPY FOR BLOOD VESSEL DEGENERATION
14 20090169613 TARGETING OF TUMOR STEM CELLS THROUGH SELECTIVE SILENCING OF BORIS EXPRESSION
15 20090081245 ASSAYS FOR DEVELOPMENT OF BORIS MUTANTS SUITABLE FOR VACCINE DEVELOPMENT AND SMALL MOLECULE INHIBITORS OF WILD-TYPE BORIS
16 20090053182 ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
17 20080260704 Combination Treatment of Cardiovascular Disease
18 20080254005 Stem Cell Therapy for the Treatment of Autism and Other Disorders
19 20080159998 STEM CELL MEDIATED TREG ACTIVATION/EXPANSION FOR THERAPEUTIC IMMUNE MODULATION
20 20080050347 STEM CELL THERAPY FOR CARDIAC VALVULAR DYSFUNCTION
21 20070269406 Transcatheter tumor immunoembolization
22 20070041954 Compositions of placentally-derived stem cells for the treatment of cancer
23 20060165665 Immunomodulation using altered dendritic cells
24 20050169944 Increasing tumor oxygen content by administration of stressed cells

I have given all that I can to this stock and the investors interest that I genuinely care about. Why do I give a damn? I wish I could answer that beyond saying that that is just me. For good or for bad. That is how I am.

For what it is worth, I have so very much faith in this science and the doctors seeing it come to the world. I am even stronger in it now than I was when my unwitting participation in this war with the thieving dogs of the world began.

So, on that, goodnight most and trade in the morning and as the days or weeks ensue as your brain matter and conscience will guide. And for the rest of ya, looking for you to take that long walk off a short pier into shark infested waters, STILL! 

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

The Resumption of Nykredit Invest Balance Investments Announced

Updated Category News Views 191

Nykredit Invest Balance Lifts Suspension for Investments It is with great news that Nykredit Portefølje Administration A/S has announced the suspension lift for several of its investment funds. Investors looking to engage their resources can now successfully allocate into the specified divisions. This significant step means investors can restart their activities in...

Continue Reading
Chaince Digital Holdings Secures $6.14 Million Investment Boost

Updated Category News Views 76

Chaince Digital Holdings Completes Investment Round Chaince Digital Holdings Inc. (“Chaince” or the “Company”) (Nasdaq: CD), a leading fintech and digital asset-focused firm, has just finalized a private placement with institutional investors. This strategic move has brought in approximately US$6.14 million, underscoring robust investor confidence in the Company's...

Continue Reading
Alpha Modus Announces Successful Business Combination Launching AMOD

Updated Category News Views 131

Alpha Modus Completes Merger with Insight Acquisition Corp Alpha Modus Holdings, Inc. is excited to share the successful closure of its business combination with Insight Acquisition Corp. This merger positions Alpha Modus to begin trading its common stock under the ticker symbol "AMOD" on the Nasdaq Global Market. Significance of the Business Combination This strategic...

Continue Reading
Olympic Steel's Resilient Performance: Q3 2024 Financial Insights

Updated Category News Views 146

Overview of Olympic Steel's Financial Results Olympic Steel (ZEUS), a prominent metals service center, has recently reported its financial performance for the third quarter of 2024. The company achieved a net income of $2.7 million and an impressive earnings before interest, taxes, depreciation, and amortization (EBITDA) of $15 million. While these figures mark a decline...

Continue Reading
Lucid Software Earns Spot Among Top Innovators for 2025

Updated Category News Views 378

Lucid Software Recognized as a Top Innovator for 2025 Lucid Software, a prominent leader in visual collaboration, has been honored by Fast Company as one of the World's Most Innovative Companies for 2025. This acknowledgement emphasizes the company's dedication to revolutionizing team collaboration, enabling organizations to operate more efficiently and effectively....

Continue Reading